Responses
Regular and Young Investigator Award Abstracts
Clinical Trial In Progress
776 Long-term efficacy and safety of lifileucel tumor-infiltrating lymphocyte (TIL) cell therapy in patients with advanced melanoma: a 4-year analysis of the C-144–01 study
Compose a Response to This Article
Other responses
No responses have been published for this article.
